Eloquest Healthcare, Inc.

Eloquest Healthcare, Inc. Eloquest Healthcare, Inc. is a wholly owned subsidiary of Ferndale Pharma Group, Inc.

that is focused specifically on serving hospitals, their healthcare practitioners, and patients. Eloquest Healthcare helps deliver safer, more compassionate care by providing intuitive, cost-effective solutions that aid in the prevention of hospital acquired infections.

Cardiac patients. High stakes. No room for dislodgment.Hear how one nurse is using Mastisol to help keep dressings secur...
03/04/2026

Cardiac patients. High stakes. No room for dislodgment.

Hear how one nurse is using Mastisol to help keep dressings secure when it matters most.

When adherence improves, clinicians can focus less on rescue and more on care.

See the full testimonial below 👇

A cornerstone of Eloquest Healthcare’s YouTube channel is our “3 Questions With” interview series.We’ve shared more than...
03/02/2026

A cornerstone of Eloquest Healthcare’s YouTube channel is our “3 Questions With” interview series.

We’ve shared more than 30 clinician perspectives so far — with more voices coming in 2026.

Our most-viewed interview features Kayla Jordan, who shares thoughtful insights on vascular access and improving patient outcomes.

🎥 Watch the interview: https://bit.ly/4rbkTb7

If you find value in these peer perspectives, consider subscribing to stay updated on future conversations.

In 2025, Eloquest Healthcare showed up at 135 in-person events nationwide — supporting everything from national nursing ...
02/27/2026

In 2025, Eloquest Healthcare showed up at 135 in-person events nationwide — supporting everything from national nursing conferences to local educational programs.

We’re continuing the momentum in 2026. Want to see where we’ll be this March?
Check out our events calendar:
https://bit.ly/4kWlLig

We hope our paths cross soon.

From early surgical literature to today’s vascular access standards, Mastisol’s longevity tells a rare story in healthca...
02/20/2026

From early surgical literature to today’s vascular access standards, Mastisol’s longevity tells a rare story in healthcare: innovation that endures because it works.🔗 Read the blog - A Century of Adhesion: The Enduring Legacy of Mastisol
https://bit.ly/4rVXF9G

When dressings hold, everything else gets easier.Fewer disruptions.Less rework.More time for what matters most — patient...
02/13/2026

When dressings hold, everything else gets easier.

Fewer disruptions.

Less rework.

More time for what matters most — patient care.

This is what can happen when adhesion performs the way it should.

See how this team improved outcomes: https://bit.ly/3MDHleK

After incorporating Mastisol, this facility started noticing something important.Fewer compromised dressings.More consis...
02/09/2026

After incorporating Mastisol, this facility started noticing something important.

Fewer compromised dressings.
More consistent adhesion.
A reliable barrier that held for extended periods.

That kind of stability matters when your goal is protecting site integrity and supporting infection prevention.
See how Mastisol fits into real-world vascular access care.
👉 Learn more https://bit.ly/4chWEEi

❗A challenge that requires both clinical judgment and evidence-based guidance: Pediatric Vascular Access. ☝️Discover the...
02/05/2026

❗A challenge that requires both clinical judgment and evidence-based guidance: Pediatric Vascular Access.

☝️Discover the right PICC securement approach essential to balancing catheter stability with skin protection for the pediatric population in our latest vlog here https://bit.ly/4qdggwB

🚨 The Pitt Spoiler Alert 🚨In a recent episode of the award-winning medical drama The Pitt, clinicians struggled to get l...
02/05/2026

🚨 The Pitt Spoiler Alert 🚨

In a recent episode of the award-winning medical drama The Pitt, clinicians struggled to get leads to adhere to a patient’s back.

A familiar challenge. A familiar solution.

So they reached for “the sticky stuff.”

From the big screen to real life, Mastisol is the clinically proven “sticky stuff” clinicians rely on to adhere dressings, tapes, and devices—when adhesion actually matters.

Ready to bring big-screen solutions into your facility?
https://bit.ly/3NZbhCr

🔥 Closing out IV Nurses Week with a focus on protecting patients’ skin.The INS Infusion Therapy Standards of Practice no...
01/30/2026

🔥 Closing out IV Nurses Week with a focus on protecting patients’ skin.

The INS Infusion Therapy Standards of Practice note that enhanced dressing securement requires additional precautions during removal to minimize the risk of skin injury.

They’re not alone! ISPAD recommends Detachol for safe removal of adhesive CGM devices, and ECRI listed proper removal as a key strategy for reducing MARSI in their 2025 Health Technology Hazard report.

Detachol is designed to complement the dressing care process — providing thoughtful, safe removal so you can choose the appropriate securement and dressing to keep the insertion site protected.

💡 Learn more about how Eloquest Healthcare products align with the INS Standards: https://bit.ly/4c0cl2I

The INS 2024 Infusion Therapy Standards of Practice emphasize the importance of assessing vascular access sites and dres...
01/28/2026

The INS 2024 Infusion Therapy Standards of Practice emphasize the importance of assessing vascular access sites and dressing integrity to reduce complications like CLABSI and hospital-onset bacteremia (HOB).

Regular assessment, collaborative rounding, and audit & feedback are key strategies for improving practice and patient outcomes. Part of this includes evaluating whether adjuncts like gum mastic adhesive (Mastisol) are helping maintain dressing integrity post-implementation.

As INS notes, understanding your process measures—not just outcome measures—is critical. Tracking dressing integrity ensures interventions actually make a difference.

💡 Learn more about putting INS Standards into practice and strategies to improve vascular access care here: https://bit.ly/4bVvK4P

🔥 It’s IV Nurses Week — and today we’re focusing on catheter securement.The INS Infusion Therapy Standards of Practice e...
01/26/2026

🔥 It’s IV Nurses Week — and today we’re focusing on catheter securement.

The INS Infusion Therapy Standards of Practice emphasize that VADs must be securely stabilized to prevent dislodgement and movement at the insertion site without hindering assessment or therapy delivery (Standard 36).

SecurAcath, a subcutaneous anchor securement system (SASS), is a standards‑supported option that stabilizes catheters throughout dwell time, reducing the risks of migration and early removal.

Important: Sutures are not recommended for securement, as they increase the risk of needlestick injuries, support biofilm growth, and may contribute to catheter-associated bloodstream infections.

Want to dive deeper into the evidence behind advanced securement devices and their impact on patient safety? Check out this blog post: https://bit.ly/45xRboR

🔥 We’re fired up for IV Nurses Week!Next week, the Infusion Nurses Society (INS) will be sharing educational content to ...
01/23/2026

🔥 We’re fired up for IV Nurses Week!

Next week, the Infusion Nurses Society (INS) will be sharing educational content to support continued learning and professional growth across infusion nursing. Check out the schedule here:https://bit.ly/49RyY6Z

We’ll be joining in by sharing standards-based resources throughout the week—focused on igniting health and inspiring hope. Stay tuned.

Address

780 W 8 Mile Road
Ferndale, MI
48220

Website

Alerts

Be the first to know and let us send you an email when Eloquest Healthcare, Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category